These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23738911)

  • 1. Disturbed protein-protein interaction networks in metastatic melanoma are associated with worse prognosis and increased functional mutation burden.
    Schramm SJ; Li SS; Jayaswal V; Fung DC; Campain AE; Pang CN; Scolyer RA; Yang YH; Mann GJ; Wilkins MR
    Pigment Cell Melanoma Res; 2013 Sep; 26(5):708-22. PubMed ID: 23738911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis.
    Tembe V; Schramm SJ; Stark MS; Patrick E; Jayaswal V; Tang YH; Barbour A; Hayward NK; Thompson JF; Scolyer RA; Yang YH; Mann GJ
    Pigment Cell Melanoma Res; 2015 May; 28(3):254-66. PubMed ID: 25490969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in malignant melanoma.
    Völler D; Ott C; Bosserhoff A
    Clin Biochem; 2013 Jul; 46(10-11):909-17. PubMed ID: 23360785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network-based co-expression analysis for exploring the potential diagnostic biomarkers of metastatic melanoma.
    Wang LX; Li Y; Chen GZ
    PLoS One; 2018; 13(1):e0190447. PubMed ID: 29377892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of microRNAs in melanoma.
    Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
    Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients.
    Schlaak M; Bajah A; Podewski T; Kreuzberg N; von Bartenwerffer W; Wardelmann E; Merkelbach-Bruse S; Büttner R; Mauch C; Kurschat P
    Br J Dermatol; 2013 Apr; 168(4):708-16. PubMed ID: 23528057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA regulation of melanoma progression.
    Bonazzi VF; Stark MS; Hayward NK
    Melanoma Res; 2012 Apr; 22(2):101-13. PubMed ID: 22209751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of galectin-3 expression with melanoma progression and prognosis.
    Brown ER; Doig T; Anderson N; Brenn T; Doherty V; Xu Y; Bartlett JM; Smyth JF; Melton DW
    Eur J Cancer; 2012 Apr; 48(6):865-74. PubMed ID: 22071132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome.
    Jönsson G; Busch C; Knappskog S; Geisler J; Miletic H; Ringnér M; Lillehaug JR; Borg A; Lønning PE
    Clin Cancer Res; 2010 Jul; 16(13):3356-67. PubMed ID: 20460471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression network analysis identified that plakophilin 1 is associated with the metastasis in human melanoma.
    Wang HZ; Wang F; Chen PF; Zhang M; Yu MX; Wang HL; Zhao Q; Liu J
    Biomed Pharmacother; 2019 Mar; 111():1234-1242. PubMed ID: 30841437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
    Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
    Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma inhibitory activity promotes melanoma development through activation of YBX1.
    Schmid R; Meyer K; Spang R; Schittek B; Bosserhoff AK
    Pigment Cell Melanoma Res; 2013 Sep; 26(5):685-96. PubMed ID: 23672612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of primary cutaneous melanoma.
    Winnepenninckx V; Van den Oord JJ
    Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease progression and patient survival are significantly influenced by BRAF protein expression in primary melanoma.
    Safaee Ardekani G; Jafarnejad SM; Khosravi S; Martinka M; Ho V; Li G
    Br J Dermatol; 2013 Aug; 169(2):320-8. PubMed ID: 23550516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information.
    Jayawardana K; Schramm SJ; Haydu L; Thompson JF; Scolyer RA; Mann GJ; Müller S; Yang JY
    Int J Cancer; 2015 Feb; 136(4):863-74. PubMed ID: 24975271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors.
    Winnepenninckx V; van den Oord JJ
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1611-31. PubMed ID: 18020928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AKT1 as the PageRank hub gene is associated with melanoma and its functional annotation is highly related to the estrogen signaling pathway that may regulate the growth of melanoma.
    Zhao J; Zeng X; Song P; Wu X; Shi H
    Oncol Rep; 2016 Oct; 36(4):2087-93. PubMed ID: 27573172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.
    Edlundh-Rose E; Egyházi S; Omholt K; Månsson-Brahme E; Platz A; Hansson J; Lundeberg J
    Melanoma Res; 2006 Dec; 16(6):471-8. PubMed ID: 17119447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular biomarkers of prognosis in melanoma: how far are we from the clinic?
    Schramm SJ; Menzies AM; Mann GJ
    Melanoma Res; 2013 Dec; 23(6):423-5. PubMed ID: 24165033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.